Tissue-Engineered “Metastases”: Treatment of Hepatic Colon Tumors with a Dual Action Autotaxin Inhibitor-Lysophosphatidic Acid Receptor Antagonist . J. Can. Res. Updates. 2021;1(1):69-77. doi:10.6000/1929-2279.2012.01.01.11